tiprankstipranks
TipRanksTop Financial ExpertsInsidersCharles Homcy

Charles Homcy Insider Profile

4 Followers
Charles Homcy, Director at BridgeBio Pharma, holds 919.88K shares in BridgeBio Pharma (Ticker: BBIO), holds ― shares in Pliant Therapeutics (Ticker: PLRX), holds 31.11K shares in Maze Therapeutics, Inc. (Ticker: MAZE).
See the Hottest Stocks Based on Insider Trading >
tipranks
Charles Homcy

Charles Homcy
BridgeBio Pharma (BBIO)
Director

Ranked #75,909 out of 109,030 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-24.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$67M
98.73%
1.14%
0.13%
0.00%
0.00% Others
A breakdown of Charles Homcy's holdings
See the Top Stocks by Insiders

Insider Roles

BridgeBio Pharma
(BBIO)
Director
Maze Therapeutics, Inc.
(MAZE)
Director
Geron
(GERN)
Director
Pliant Therapeutics
(PLRX)
Director
+1 other positions
Roles that Charles Homcy holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Global Blood Therapeutics
(GBT)
Rating:Informative Sell
Date:Oct 27, 2017 - Oct 27, 2018
Return:-4.50%
The most profitable trade made by Charles Homcy
See the Latest Stocks Traded by Insiders

Charles Homcy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BBIO
BridgeBio Pharma
Jun 24, 2026
Director
Uninformative Buy
―
$66.58M
PLRX
Pliant Therapeutics
―
Director
―
―
MAZE
Maze Therapeutics, Inc.
May 06, 2026
Director
Uninformative Sell
―
$767.56K
PTLA
Portola Pharma
Jun 08, 2018
―
Uninformative Buy
―
$5.37M
MYOK
MyoKardia
―
―
―
―
GBT
Global Blood Therapeutics
Oct 27, 2017
―
Informative Sell
2.38M
$4.75M
GERN
Geron
May 13, 2011
Director
Uninformative Buy
―
$85.97K
CYTK
Cytokinetics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Charles Homcy's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Charles Homcy insider profile FAQ

What is the percentage of profitable transactions made by Charles Homcy?
The percentage of profitable transactions made by Charles Homcy is 0%.
    What is the average return per transaction made by Charles Homcy?
    The average return per transaction made by Charles Homcy is -24.10%.
      What stocks does Charles Homcy hold?
      Charles Homcy holds: BBIO, PLRX, MAZE, PTLA, MYOK, GBT, GERN, CYTK stocks.
        What was Charles Homcy’s latest transaction?
        Charles Homcy latest transaction was an Uninformative Buy of ―.
          What was Charles Homcy's most profitable transaction?
          Charles Homcy’s most profitable transaction was an Informative Sell of GBT stock on October 27, 2017. The return on the trade was -4.50%.
            What is Charles Homcy's role in BridgeBio Pharma?
            Charles Homcy's role in BridgeBio Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.